Patents expiring in 2030

US 7666427

HIV vaccines based on Env of multiple clades of HIV

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666867

Heteroindanes: a new class of potent cannabimimetic ligands

UNIVERSITY OF CONNECTICUT · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666674

Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666842

Elastin peptide analogs and uses thereof

Connective Tissue Imagineering, LLC · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666619

Compounds and methods for regulating bacterial growth and pathogenesis

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666846

Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666581

Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease

University of Connecticut Health Center · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7668662

Patient-specific dosimetry

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7670599

YKL-40 as a marker and prognostic indicator for cancers

The Regents of the University of California · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7670767

Genetic alterations associated with cancer

The Board of Regents of the University of Texas System · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7670600

Molecules with extended half-lives, compositions and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7670806

ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7671198

Process for preparing intermediates to 5-HT4 receptor agonist compounds

Theravance, Inc. · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7671174

Ligand to GPR8

Takeda Pharmaceutical Company Limited · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7671058

N-(3,4-disubstituted phenyl) salicylamide derivatives

Institute of Medicinal Molecular Design, Inc. · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7671071

Polymorphic Form XVI of fexofenadine hydrochloride

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7671221

Modulators of ATP-Binding Cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7670855

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

The Regents of the University of California · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674249

Gels with predetermined conductivity used in electroporation of tissue

The Regents of the University of California · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674879

Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674778

Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674777

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674480

Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674779

RNAi modulation of MLL-AF4 and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674787

Conformationally constrained Smac mimetics and the uses thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674935

Crystal forms of O-desmethylvenlafaxine

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674953

Method for producing transgenic plants with increased yield, comprising expressing of haemoglobin from Arabidopsis

CropDesign N.V. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674923

Process for preparing forms of atorvastatin calcium substantially free of impurities

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7674908

Indazole-carboxamide compounds as 5-HT4 receptor agonists

Theravance, Inc. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678938

Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678922

Processes for the preparation of 1,2,4-oxadiazole benzoic acids

PTC THERAPEUTICS, INC. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678824

Methods for treatment with bucindolol based on genetic targeting

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678813

Azadecalin Glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678552

Method for selecting therapeutic agents for cancer treatment

Precision Therapeutics, Inc. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678386

Liposomes coated with selected antibodies that bind to aminophospholipids

The Board of Regents of the University of Texas · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678387

Drug delivery systems

Capricorn Pharma Inc. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678569

Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678802

Quinazolines useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678799

Crystalline ziprasidone HCl and processes for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678764

Protein formulations for use at elevated temperatures

JOHNSON & JOHNSON REGENERATIVE THERAPEUTICS, LLC · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678816

Method of stabilizing lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678918

Intermediates for imidazonaphthyridines

Graceway Pharmaceuticals. LLC · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678828

Methods for the formulation and manufacture of artesunic acid for injection

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7678890

Compositions and methods of treating disease with FGFR fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2010030203

ANTICORPS MONOCLONAL DIRIGÉ CONTRE LA TRANSTHYRÉTINE HUMAINE AMYLOÏDOGÈNE ET DES FORMES MODIFIÉES DE CELLE-CI ET SON UTILISATION DANS LA DÉTECTION ET LE TRAITEMENT DE LA FAP ET DE PATHOLOGIES PRÉSENTANT UNE TTR MODIFIÉE

BIOCODEX INCUBACAO DE EMPRESAS [PT] · Granted Thu Mar 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683173

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683082

1,2,4-oxadiazole benzoic acid compositions and their use in bioassays

PTC THERAPEUTICS, INC. · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683041

Microgel particles for the delivery of bioactive materials

The Regents of the University of California · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)